Josh DeClercq
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Medication Adherence and Compliance 10
-
- Multiple Sclerosis Research Studies 6
- Co-authors
- Leena Choi (36 shared papers)Autumn D. Zuckerman (31 shared papers)Nisha B. Shah (14 shared papers)David G. M. Mitchell (2 shared papers)Nitin B. Jain (3 shared papers)Gregory Dan Ayers (1 shared paper)Elizabeth G. Matzkin (1 shared paper)Laurence D. Higgins (1 shared paper)
- Journals
- Journal of Managed Care & Specialty Pharmacy (8 papers)American Journal of Health-System Pharmacy (5 papers)Journal of the American Pharmacists Association (5 papers)Multiple Sclerosis and Related Disorders (2 papers)JAMA (2 papers)
- Partner nations
- United StatesFranceBermuda
In The Last Decade
Josh DeClercq
43 papers receiving 437 citations
Peers
Comparison fields: 5 of 57
- Family Practice 82
- Geriatrics and Gerontology 38
- Hepatology 19
- Infectious Diseases 29
- Surgery 65
Countries citing papers authored by Josh DeClercq
This map shows the geographic impact of Josh DeClercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh DeClercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh DeClercq more than expected).
Fields of papers citing papers by Josh DeClercq
This network shows the impact of papers produced by Josh DeClercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh DeClercq. The network helps show where Josh DeClercq may publish in the future.
Co-authors
The 25 scholars most cited alongside Josh DeClercq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2023 | 37 | |
| 3 | 2019 | 31 | |
| 4 | 2020 | 28 | |
| 5 | 2022 | 18 | |
| 6 | 2020 | 17 | |
| 7 | 2016 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2022 | 14 | |
| 10 | 2019 | 13 | |
| 11 | 2023 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2023 | 10 | |
| 16 | 2022 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2019 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2021 | 7 |
About Josh DeClercq
Josh DeClercq is a scholar working on Family Practice, Pathology and Forensic Medicine, Hepatology, Pharmacology and Infectious Diseases, having authored 48 papers that have together received 453 indexed citations. Recurring topics across this work include Medication Adherence and Compliance (10 papers), Multiple Sclerosis Research Studies (6 papers), Cannabis and Cannabinoid Research (4 papers), Hepatitis C virus research (3 papers), COVID-19 Clinical Research Studies (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Pharmaceutical Economics and Policy (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). The work is most often cited by research in Family Practice (82 citations), Geriatrics and Gerontology (38 citations), Hepatology (19 citations), Infectious Diseases (29 citations) and Surgery (65 citations). Josh DeClercq has collaborated with scholars based in United States, France and Bermuda. Frequent co-authors include Leena Choi, Autumn D. Zuckerman, Nisha B. Shah, David G. M. Mitchell, Nitin B. Jain, Gregory Dan Ayers, Elizabeth G. Matzkin, Laurence D. Higgins, Keith M. Baumgarten and Anna Ryan Hemnes. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, American Journal of Health-System Pharmacy, Journal of the American Pharmacists Association, Multiple Sclerosis and Related Disorders and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.